ChemSpider 2D Image | Alisol B | C30H48O4

Alisol B

  • Molecular FormulaC30H48O4
  • Average mass472.700 Da
  • Monoisotopic mass472.355255 Da
  • ChemSpider ID24608526

  • defined stereocentres - 9 of 9 defined stereocentres

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(8α,9β,11β,14β,20R,23S,24R)-11,23-Dihydroxy-24,25-epoxydammar-13(17)-en-3-on [German] [ACD/IUPAC Name]
(8α,9β,11β,14β,20R,23S,24R)-11,23-Dihydroxy-24,25-epoxydammar-13(17)-en-3-one [ACD/IUPAC Name]
(8α,9β,11β,14β,20R,23S,24R)-11,23-Dihydroxy-24,25-époxydammar-13(17)-én-3-one [French] [ACD/IUPAC Name]
(8α,9β,11β,14β,23S,24R)-11,23-Dihydroxy-24,25-epoxydammar-13(17)-en-3-on [German] [ACD/IUPAC Name]
(8α,9β,11β,14β,23S,24R)-11,23-Dihydroxy-24,25-epoxydammar-13(17)-en-3-one [ACD/IUPAC Name]
(8α,9β,11β,14β,23S,24R)-11,23-Dihydroxy-24,25-époxydammar-13(17)-én-3-one [French] [ACD/IUPAC Name]
18649-93-9 [RN]
Alisol B
Dammar-13(17)-en-3-one, 24,25-epoxy-11,23-dihydroxy-, (8α,9β,11β,14β,20R,23S,24R)- [ACD/Index Name]
Dammar-13(17)-en-3-one, 24,25-epoxy-11,23-dihydroxy-, (8α,9β,11β,14β,23S,24R)- [ACD/Index Name]
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions. MedChem Express
      Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions.; IC50 Value:; Target:; In vitro: The in vitro cultur ed human renal tubular epithelial HK-2 cells were intervened with 5 ng/mL transforming growth factor-beta (TGF-beta), 0.1 micromol C3a, and 0.1 micromol C3a + 10 micromol alisol B, respectively. MedChem Express HY-N0805A
      Alisol B is a potentially novel therapeutic compound for bone disorders by targeting the differentiation of osteoclasts as well as their functions.;IC50 Value:;Target:;In vitro: The in vitro cultured human renal tubular epithelial HK-2 cells were intervened with 5 ng/mL transforming growth factor-beta (TGF-beta), 0.1 micromol C3a, and 0.1 micromol C3a + 10 micromol alisol B, respectively. Exogenous C3a could induce renal tubular EMT. Alisol B was capable of suppressing C3a induced EMT [1]. Alisol-B strongly inhibited RANKL-induced osteoclast formation when added during the early stage of cultures, suggesting that alisol-B acts on osteoclast precursors to inhibit RANKL/RANK signaling. Among the RANK signaling pathways, alisol-B inhibited the phosphorylation of JNK, which are upregulated in response to RANKL in bone marrow macrophages, alisol-B also inhibited RANKL-induced expression of NFATc1 and c-Fos, which are key transcription factors for osteoclastogenesis. In addition, alisol- MedChem Express HY-N0805A
      Others MedChem Express HY-N0805A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.1±0.1 g/cm3
Boiling Point: 575.1±50.0 °C at 760 mmHg
Vapour Pressure: 0.0±3.6 mmHg at 25°C
Enthalpy of Vaporization: 98.9±6.0 kJ/mol
Flash Point: 179.1±23.6 °C
Index of Refraction: 1.554
Molar Refractivity: 135.0±0.4 cm3
#H bond acceptors: 4
#H bond donors: 2
#Freely Rotating Bonds: 4
#Rule of 5 Violations: 1
ACD/LogP: 5.40
ACD/LogD (pH 5.5): 5.68
ACD/BCF (pH 5.5): 12180.36
ACD/KOC (pH 5.5): 29248.53
ACD/LogD (pH 7.4): 5.68
ACD/BCF (pH 7.4): 12180.36
ACD/KOC (pH 7.4): 29248.53
Polar Surface Area: 70 Å2
Polarizability: 53.5±0.5 10-24cm3
Surface Tension: 45.3±5.0 dyne/cm
Molar Volume: 421.5±5.0 cm3

Click to predict properties on the Chemicalize site


Advertisement